Paper
0
A Randomised Comparison of CPX-351 Versus Standard Daunorubicin and Cytarabine Plus Fractionated Gemtuzumab Ozogamicin in Older Adults with AML without Adverse Risk Cytogenetics: Results of the NCRI AML18 Trial
Authors
Steven Knapper,Laura Dillon
Malavika Babu,Abin Thomas,Ian Thomas,Christopher Hourigan,Georgia Andrew,Richard Dillon,Amanda Gilkes,Nuria Almuina,Sophie King,Thomas Coats,Nicholas McCarthy,Jenny Byrne,Simone Green,Ulrik Overgaard,Leanne Berkahn,Lara Stone,Rasha Al-Ali,Reem Bahr,Rob Sellar,Mike Dennis,Priyanka Mehta,Robert Hills,Sylvie Freeman
+23 authors
,Nigel RussellJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.